Teijin Second Quarter 2025 Earnings: JP¥309 loss per share (vs JP¥12.46 loss in 2Q 2024)
Teijin (TSE:3401) Second Quarter 2025 Results
Key Financial Results
- Revenue: JP¥252.2b (down 3.6% from 2Q 2024).
- Net loss: JP¥59.6b (loss widened by JP¥57.2b from 2Q 2024).
- JP¥309 loss per share (further deteriorated from JP¥12.46 loss in 2Q 2024).
All figures shown in the chart above are for the trailing 12 month (TTM) period
Teijin Earnings Insights
Looking ahead, revenue is forecast to grow 2.8% p.a. on average during the next 3 years, compared to a 5.1% growth forecast for the Chemicals industry in Japan.
Performance of the Japanese Chemicals industry.
The company's shares are up 3.1% from a week ago.
Risk Analysis
We don't want to rain on the parade too much, but we did also find 2 warning signs for Teijin that you need to be mindful of.
Valuation is complex, but we're here to simplify it.
Discover if Teijin might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.
Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About TSE:3401
Teijin
Engages in the fibers, films and sheets, composites, healthcare, and IT businesses worldwide.
Undervalued with moderate growth potential.
